Skip to content

Treatment of Nidranasha by Jatamansi Churna and Nirgundi Taila Padabhyanga

A Study on Nidra and evaluation of the effect of Jatamansi Churna and Nirgundi Taila Padabhyanga in Nidranasha

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047445
Enrollment
40
Registered
2022-11-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z00-Z99- Factors influencing health status and contact with health services

Interventions

None listed

Sponsors

Manasi Pradhan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having Nidranasha as per clinical sign and symptoms as in classical text. 2.Patients of both the sex in the age between 30-70 yrs. 3.Patients without any systemic disorders. 4.Patient is having difficulty in initiating sleep even after one hour.

Exclusion criteria

Exclusion criteria: 1.Patients suffering from other systemic illness and metabolic disorders. 2.Patients of both sex in the age below 30 and above 70 years. 3.Patient who are on psychiatric treatment. 4.Accident cases, post-operative cases, drug abuser, alcohol addicted, mentally retarded and psychiatric abnormalities, pregnant and lactating mother.

Design outcomes

Primary

MeasureTime frame
To control the symptoms of Nidranasha by the internal application of Jatamansi Churna.Timepoint: 15 Days

Secondary

MeasureTime frame
Internal application Jatamansi Churna and Nirgundi Taila Padabhyanga are more effective than the internal application of Jatamansi Churna in Nidranasha.Timepoint: 15 Days

Countries

India

Contacts

Public ContactProf Dr Arun Ku Das

Govt Ayurvedic College and Hospital Balangir

dasarun1969@gmail.com9861229623

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026